1983
DOI: 10.1073/pnas.80.14.4349
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.

Abstract: Chemoattractant N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) in the presence of cytochalasin B stimulates the release of leukotriene B4 (LTB4), superoxide (02) The influx and activation of neutrophils [PMN (polymorphonuclear leukocytes)] are essential for induction of inflammatory processes (1, 2). The chemoattractant N-formylmethionylleucylphenylalanine (fMet-Leu-Phe) and products of complement activation such as Ca recruit and activate the PMN to release active oxygen species and undergo degranulation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
114
1
1

Year Published

1987
1987
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 246 publications
(120 citation statements)
references
References 27 publications
(19 reference statements)
3
114
1
1
Order By: Relevance
“…Thus, free AA appears to be differentially metabolized by the two pathways, with higher concentrations eventually favoring the production of PGE 2 over that of LTB 4 . PGE 2 is well known for its capacity to prevent LTB 4 generation from neutrophils [13,16]; thus, in the present set of experiments where 5-LO-and COX-derived metabolites can be simultaneously produced, extracellular concentrations of PGE 2 may potentially reach levels which could explain, at least in part, the blunted biosynthesis of LTB 4 obtained when AA concentrations increase. This specific issue was addressed by two pharmacological approaches.…”
Section: Arachidonic Acid Utilizationmentioning
confidence: 89%
“…Thus, free AA appears to be differentially metabolized by the two pathways, with higher concentrations eventually favoring the production of PGE 2 over that of LTB 4 . PGE 2 is well known for its capacity to prevent LTB 4 generation from neutrophils [13,16]; thus, in the present set of experiments where 5-LO-and COX-derived metabolites can be simultaneously produced, extracellular concentrations of PGE 2 may potentially reach levels which could explain, at least in part, the blunted biosynthesis of LTB 4 obtained when AA concentrations increase. This specific issue was addressed by two pharmacological approaches.…”
Section: Arachidonic Acid Utilizationmentioning
confidence: 89%
“…Ham et al (26) were the first to demonstrate that PGE 2 inhibited LT biosynthesis. Although much effort has been focused on understanding the mechanism by which PG inhibit 5-LO metabolism in cells, such as PMN, little is known about the regulation of LT metabolism in DC.…”
Section: Discussionmentioning
confidence: 99%
“…However, PGE 2 may also contribute to dysregulated inflammatory responses by increasing vascular permeability that facilitates influx of pro-inflammatory polypeptides. While PGE 2 prolongs neutrophil half-life through upregulation of intracellular cAMP levels and inhibition of apoptosis [113], it also attenuates PMA-, fMLP-or GM-CSF-stimulated ROS and LTB 4 production in neutrophils [114][115][116][117]. The Th2 cytokine IL-13 was found to increase neutrophil PGE 2 production concomitant with increased expression of complement receptor type 1 (CR1) and type 3 (CR3), and increased neutrophil phagocytosis [118].…”
Section: Pgementioning
confidence: 99%